Comparison Chart Mesoblast Limited OTC Markets

Stocks

MEOBF

AU000000MSB8

Biotechnology & Medical Research

Market Closed - OTC Markets 10:51:57 2026-08-10 EDT			5-day change	1st Jan Change
1.890 ^USD	+11.18%		0.00%	-0.53%

08-17	Mesoblast Limited Completes Patient Treatment In Pivotal Phase 3 Trial Of Rexlemestrocel-L For Chronic Low Back Pain	CI
08-17	Mesoblast Completes Patient Treatment in Phase 3 Trial of Chronic Low Back Pain	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	MESOBLAST LIMITED	Other Biotechnology & Medical Research	+11.18%	0.00%	-0.53%	+22.73%	+29.45%	2.19B	-	-	-